Muplestim

Muplestim
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Muplestim is a recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) analog used primarily in the treatment of neutropenia, a condition characterized by an abnormally low concentration of neutrophils in the blood. Neutrophils are a type of white blood cell essential for combating infections, particularly bacterial and fungal infections.

Mechanism of Action

Muplestim functions by stimulating the bone marrow to produce more white blood cells, specifically neutrophils. It binds to the GM-CSF receptor on hematopoietic progenitor cells, activating intracellular signaling pathways that lead to the proliferation and differentiation of these cells into mature neutrophils. This process enhances the body's ability to fight infections.

Clinical Uses

Muplestim is primarily indicated for patients undergoing chemotherapy who are at risk of developing neutropenia. It is also used in patients with congenital neutropenia, cyclic neutropenia, and idiopathic neutropenia. By increasing neutrophil counts, Muplestim reduces the incidence of febrile neutropenia and associated complications.

Administration and Dosage

Muplestim is administered via subcutaneous injection. The dosage and frequency depend on the patient's condition, weight, and response to treatment. It is typically given daily until the patient's neutrophil count returns to a safe level.

Side Effects

Common side effects of Muplestim include bone pain, fever, fatigue, and injection site reactions. Less common but more serious side effects can include splenic rupture, acute respiratory distress syndrome, and allergic reactions. Patients should be monitored for these adverse effects during treatment.

Contraindications

Muplestim is contraindicated in patients with a known hypersensitivity to GM-CSF or any component of the formulation. Caution is advised in patients with pre-existing pulmonary conditions or those with a history of splenic disorders.

Research and Development

Muplestim is the result of extensive research into cytokine biology and the role of GM-CSF in hematopoiesis. Ongoing studies are exploring its potential use in other conditions, such as bone marrow transplantation and as an adjuvant in cancer immunotherapy.

Also see

• Granulocyte colony-stimulating factor
• Neutropenia
• Chemotherapy-induced neutropenia
• Hematopoiesis